KYMR logo

Kymera Therapeutics (KYMR) return on equity

annual ROE:

-36.38%-3.17%(-9.55%)
December 31, 2024

Summary

  • As of today (July 1, 2025), KYMR annual return on equity is -36.38%, with the most recent change of -3.17% (-9.55%) on December 31, 2024.
  • During the last 3 years, KYMR annual ROE has fallen by -9.42% (-34.94%).
  • KYMR annual ROE is now -158.36% below its all-time high of 62.34%, reached on December 31, 2018.

Performance

KYMR ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRprofitability metrics

quarterly ROE:

-30.80%+1.00%(+3.14%)
March 31, 2025

Summary

  • As of today (July 1, 2025), KYMR quarterly return on equity is -30.80%, with the most recent change of +1.00% (+3.14%) on March 31, 2025.
  • Over the past year, KYMR quarterly ROE has increased by +1.42% (+4.41%).
  • KYMR quarterly ROE is now -167.68% below its all-time high of 45.51%, reached on March 31, 2020.

Performance

KYMR quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

KYMR ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-9.6%+4.4%
3 y3 years-34.9%+5.2%
5 y5 years-165.6%-167.7%

KYMR ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-34.9%at low-13.3%+15.6%
5 y5-year-165.6%+16.4%-28.2%+90.5%
alltimeall time-158.4%+16.4%-167.7%+90.5%

KYMR ROE History

DateAnnualQuarterly
Mar 2025
-
-30.80%(-3.1%)
Dec 2024
-36.38%(+9.5%)
-31.80%(+17.0%)
Sep 2024
-
-27.19%(-9.7%)
Jun 2024
-
-30.10%(-6.6%)
Mar 2024
-
-32.22%(-4.5%)
Dec 2023
-33.21%(+1.9%)
-33.74%(-7.5%)
Sep 2023
-
-36.47%(+6.4%)
Jun 2023
-
-34.28%(-1.2%)
Mar 2023
-
-34.70%(+2.6%)
Dec 2022
-32.60%
-33.81%(+0.3%)
Sep 2022
-
-33.70%(-2.0%)
DateAnnualQuarterly
Jun 2022
-
-34.38%(+5.8%)
Mar 2022
-
-32.50%(+14.2%)
Dec 2021
-26.96%(-38.1%)
-28.47%(+15.0%)
Sep 2021
-
-24.76%(+3.1%)
Jun 2021
-
-24.02%(-11.1%)
Mar 2021
-
-27.02%(-9.9%)
Dec 2020
-43.53%(-178.5%)
-29.98%(-27.0%)
Sep 2020
-
-41.09%(-87.3%)
Jun 2020
-
-322.93%(-809.6%)
Mar 2020
-
45.51%(+47.7%)
Dec 2019
55.43%(-11.1%)
30.82%
Dec 2018
62.34%
-

FAQ

  • What is Kymera Therapeutics annual return on equity?
  • What is the all time high annual ROE for Kymera Therapeutics?
  • What is Kymera Therapeutics annual ROE year-on-year change?
  • What is Kymera Therapeutics quarterly return on equity?
  • What is the all time high quarterly ROE for Kymera Therapeutics?
  • What is Kymera Therapeutics quarterly ROE year-on-year change?

What is Kymera Therapeutics annual return on equity?

The current annual ROE of KYMR is -36.38%

What is the all time high annual ROE for Kymera Therapeutics?

Kymera Therapeutics all-time high annual return on equity is 62.34%

What is Kymera Therapeutics annual ROE year-on-year change?

Over the past year, KYMR annual return on equity has changed by -3.17% (-9.55%)

What is Kymera Therapeutics quarterly return on equity?

The current quarterly ROE of KYMR is -30.80%

What is the all time high quarterly ROE for Kymera Therapeutics?

Kymera Therapeutics all-time high quarterly return on equity is 45.51%

What is Kymera Therapeutics quarterly ROE year-on-year change?

Over the past year, KYMR quarterly return on equity has changed by +1.42% (+4.41%)
On this page